Pharmaceutical Executive, Mar 1, 2009

Features

The New Sales Force

By Brittany Agro

The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with—and how it's working

Ad Stars 2009

By Brittany Agro

The faces (and talent!) behind the year's best ads

Fifth Annual Press Audit: Safety in the Spotlight

By Stephen J. Porth , George P. Sillup

Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety—and the regulators who enforce it.

Attack of the Monster Merger

By Walter Armstrong

Just when you thought it was safe to go back into M&A, the mega merger returns. What's right about Pfizer-Wyeth, and what's scary.

Columns

Activate Your Audience

Marketers need to reach beyond disease awareness to spark "movement" communications campaigns

The End of Quid Pro Quo

Exhibitor alert: Tchotchke entitlement is out, information immersion is in

Leadership

Learning From Fast-Action Obama

By Sander Flaum

Our new president came in with a 100-day plan. His execution may be less than perfect, but his make-change approach inspires confidence

From the Editor

Against Gravity

By Patrick Clinton

The worst thing about working for most corporations is the inevitable downward pull they exert even on the best of us. That's why it's always sad to lose a company that learned to fight back.